Trial Profile
A Retrospective study to evaluate the time to Tumor shrinkage with Lenvatinib treatment in patients with advanced Thyroid Carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 May 2018
Price :
$35
*
At a glance
- Drugs Lenvatinib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 29 May 2018 New trial record